HealthQuad

Thrilled to share that our portfolio company Qure.ai has raised $65 million Series D funding round led by Lightspeed India and 360 ONE. HealthQuad continued to back the company alongwith existing investors Novo Holdings and TEAMFund. As a long-standing investor, we have witnessed Qure.ai’s incredible growth and innovation, deploying their AI-powered solutions in over 3,000 sites across 90+ countries and securing 18 FDA approvals. Qure.ai’s cutting-edge technology is transforming diagnostic accuracy and speeding up early detection of critical diseases like Tuberculosis, Lung Cancer and Stroke. Their impact on global healthcare access and outcomes has been profound, touching 20 Mn+ lives, particularly in underserved regions. As we continue to champion revolutionary healthcare solutions, we remain dedicated to empowering AI-driven innovations and fostering sustainable healthcare ecosystems worldwide. Congratulations to Prashant Warier and the entire Qure.ai team on this remarkable achievement. Here’s to advancing healthcare and bridging the care gap globally! Read more here: https://lnkd.in/g_uEbcQ4 Charles-Antoine Janssen Dr. Amit Varma Sunil Thakur Ajay Mahipal DR PINAK SHRIKHANDE Divya Gulati Sakshi Bansal Shubham Jain Dr. Kanika Jain Nidhi Dahiya Manan Kalra Tushar Renjhen Devendra Sharma Manali Rajgaria

We are pleased to announce that our portfolio company Redcliffe Labs has raised USD 42 Mn in Series C funding led by IFU. HealthQuad continued to back the Company in its recent fund raise post our first investment in 2022. We remain committed to democratising access to quality and affordable preventive care through our partnership with Redcliffe. Charles-Antoine Janssen Sunil Thakur DR PINAK SHRIKHANDE Ajay Mahipal Sakshi Bansal Shubham Jain Divya Gulati Dr. Kanika Jain Nidhi Dahiya Manan Kalra Tushar Renjhen Manali Rajgaria

HealthQuad is hiring smart and enterprising candidates for a full time pre-MBA Analyst position. HealthQuad is India's leading healthcare focused Venture Capital Fund. Unique opportunity to gain hands-on experience of venture capital investing with one of India’s leading investment teams in healthcare VC. The role would entail working as part of the investment team in new deal evaluation, portfolio management and fund raise related initiatives. Location: New Delhi (candidates outside NCR should only apply if they are willing to relocate) Duration: 12-24 months (this is a pre-MBA role and hence would be determined based on candidate's background) Salary: As per industry standards The ideal candidate should demonstrate: - Strong analytical skills and steep learning curve in previous experiences - Be passionate about healthcare investing and working with smart entrepreneurs to build unicorns of tomorrow - Strong Powerpoint and financial modelling skills - 2-3 years of Finance/strategy background with leading consulting firms/investment banking/equity research and should be proficient in Powerpoint, financial modelling and valuation NOTE: We will not be accepting applications from Freshers and MBAs. Interested candidates can send their CVs to career@healthquad.in

HealthQuad is hiring smart and enterprising candidates for a full time pre-MBA Analyst position. HealthQuad is India's leading healthcare focused Venture Capital Fund. Unique opportunity to gain hands-on experience of venture capital investing with one of India’s leading investment teams in healthcare VC. The role would entail working as part of the investment team in new deal evaluation, portfolio monitoring and fund raise related initiatives. Location: New Delhi (candidates outside NCR should only apply if they are willing to relocate) Duration: 12-24 months (this is a pre-MBA role and hence would be determined based on candidate's background) Salary: As per industry standards The ideal candidate should demonstrate: - Strong analytical skills and steep learning curve in previous experiences - Be passionate about healthcare investing and working with smart entrepreneurs to build unicorns of tomorrow - Strong Powerpoint and financial modelling skills - 2-3 years of Finance/strategy background with leading consulting firms/investment banking/equity research and should be proficient in Powerpoint, financial modelling and valuation NOTE: We will not be accepting applications from Freshers and MBAs. Interested candidates can send their CVs to career@healthquad.in

We wish Prashant Warier and Qure.ai team all the best for this noble cause. Qure.ai has been at the forefront in creating healthcare accessibility in remote regions and is now about to set a World Record for the same.

DR PINAK SHRIKHANDE (Managing Director, HealthQuad) spoke recently with DealStreetAsia and shared views on the exit scenario for healthcare investments in India and and the growing investor appetite in the Indian healthcare space. HealthQuad is bullish on the India growth story and is keen to back transformative healthcare models that are solving for the mega healthcare challenges Thanks to Paramita Chatterjee for providing the opportunity to share our views Read the full interview here: https://lnkd.in/gAJstJMH

Here are the key trends that are shaping the landscape and paving the way for healthcare innovation in India. To know more, read our entire report at https://lnkd.in/gEv8dhRZ Bain & Company Charles-Antoine Janssen | Dr. Amit Varma | Sunil Thakur | DR PINAK SHRIKHANDE | Ajay Mahipal | Shubham Jain | Divya Gulati | Sakshi Bansal | Nidhi Dahiya | Manan Kalra | Vrinda Bansal | Manali Rajgaria | Devendra Sharma #healthcare #innovation #healthtech #biotech #medtech #pharma #venturecapital #investing #indiainnovation

We are delighted to announce another significant milestone for HealthQuad – our exit from Asian Institute of Nephrology and Urology (AINU), India’s largest single-specialty hospital network dedicated to Urology & Nephrology Care. The exit came as part of a majority acquisition of AINU by Asia Healthcare Holdings (backed by TPG Growth and GIC). HealthQuad sold its entire stake in the Company generating a 4x return for the Fund.   It has been a milestone deal in many ways for HealthQuad   - Created India’s largest Renal Sciences Hospital network through successful scale-up from a single flagship hospital to 7 facilities across 4 cities - Established leadership position in the country in the area of robotic urology surgery and transformed into a centre of excellence renowned across the country for performing the most complex urology cases - The deal marks HealthQuad’s fourth exit   HealthQuad invested in AINU in 2016 with a vision to bridge the shortage of hospitals providing quality renal care. India has the 6th highest prevalence of chronic-kidney disease and only ~3% patients undergo transplants each year due to lack of resources and awareness. Further, ~12% Indians suffer from urological diseases and the number is on the rise due to increasing incidence of diabetes, cardio-vascular diseases etc. The Fund’s focus on driving meaningful impact helped enhance access to care by increasing the bed capacity by 5x and patient volume by 3x and improved quality of care by providing state-of-the-art facilities, world-class medical expertise and adopting a patient-centric approach. We would like to congratulate the Promoters - Dr. C Mallikarjuna and Dr P C Reddy on the acquisition and wish them all the best for the exciting journey ahead.   Read more about the transaction here: https://lnkd.in/g4gbgzz6   Charles-Antoine Janssen Dr. Amit Varma Sunil Thakur DR PINAK SHRIKHANDE Ajay Mahipal Divya Gulati Sakshi Bansal Shubham Jain Vrinda Bansal Manan Kalra Devendra Sharma Manali Rajgaria Nidhi Dahiya

The healthcare market in India, about $180 billion in FY23, is on a dynamic growth trajectory. As per projections, healthcare market is expected to grow to $320 billion by FY28 with a CAGR of 12%. The future looks promising, with significant advancements and expansion in the horizon. To know more, visit: https://lnkd.in/gEv8dhRZ Bain & Company Charles-Antoine Janssen | Dr. Amit Varma | Sunil Thakur | PINAK SHRIKHANDE | Ajay Mahipal | Shubham Jain | Divya Gulati | Sakshi Bansal | Nidhi Dahiya | Manan Kalra | Vrinda Bansal | Manali Rajgaria | Devendra Sharma #healthcare #innovation #healthtech #biotech #medtech #pharma #venturecapital #investing #indiainnovation

HealthQuad is delighted to announce our latest investment in Cureskin. India grapples with the problem of extremely poor qualified dermatologist access (1 specialist per 112k population) coupled with lack of product knowledge and lack of curated therapies leading to ineffective self-treatment often leading to undesirable side-effects. Cureskin solves for access and quality through a personalized, easy-to-understand at-home regimen approved by qualified dermatologists through a highly precise AI-powered algorithm built on 45 Mn+ images. We look forward to our partnership with Guna Kakulapati Ramakrishna Rajanna and the entire Cureskin team to disrupt the skin and hair care industry in India through clinically-validated, customised solutions widening the reach in deeper pockets of India. Read more at: https://lnkd.in/gqrtV_iv Charles-Antoine Janssen Dr. Amit Varma Sunil Thakur PINAK SHRIKHANDE Ajay Mahipal Sakshi Bansal Nidhi Dahiya Divya Gulati Shubham Jain Vrinda Bansal Palak Vatwani Manan Kalra Manali Rajgaria Devendra Sharma